We are open as normal during COVID-19 pandemic. Order online, same day shipping out from North Carolina, USA

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 462171

CAS#: unknown

Description: BC-DXI-04 is a AIMP2-DX2 inhibitor.

Price and Availability

Size Price Shipping out time Quantity
Inquire bulk and customized quantity

Pricing updated 2020-10-20. Prices are subject to change without notice.

BC-DXI-04 is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, SDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.

Chemical Structure


Theoretical Analysis

MedKoo Cat#: 462171
Name: BC-DXI-04
CAS#: unknown
Chemical Formula: C20H34N2O5S
Exact Mass: 414.2188
Molecular Weight: 414.561
Elemental Analysis: C, 57.95; H, 8.27; N, 6.76; O, 19.30; S, 7.73

Synonym: BC-DXI-04

IUPAC/Chemical Name: (S)-N-(1-(1,4,7-trioxa-10-azacyclododecan-10-yl)-4-methylpentan-2-yl)benzenesulfonamide


InChi Code: InChI=1S/C20H34N2O5S/c1-18(2)16-19(21-28(23,24)20-6-4-3-5-7-20)17-22-8-10-25-12-14-27-15-13-26-11-9-22/h3-7,18-19,21H,8-17H2,1-2H3/t19-/m0/s1


Technical Data

Solid powder

>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:


1: Sivaraman A, Kim DG, Bhattarai D, et al. Synthesis and Structure-Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer Therapy. J Med Chem. 2020;63(10):5139‐5158. doi:10.1021/acs.jmedchem.9b01961